Brief: Chimeric Therapeutics Says Jennifer Chow Gave Notice Of Resignation As CEO, Managing Director
01/05/2024 02:21
May 1 (Reuters) - Chimeric Therapeutics Ltd CHM.AX :
* JENNIFER CHOW HAS GIVEN NOTICE OF HER RESIGNATION AS CEO,
MANAGING DIRECTOR
* EXPECTED THAT JENNIFER CHOW, CEO AND MD, WILL LEAVE CO ON
MAY 24
Further company coverage: CHM.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chimeric Therapeutics
See all newsBrief: Chimeric Therapeutics Says Phillip Hains Appointed Interim Chairman
Brief: Chimeric Therapeutics Posts Prelim Loss For Year Of A$18.8 MLN
Brief: Chimeric Therapeutics Intends To Enter Negotiations With Its Creditors
Brief: Chimeric Therapeutics Seeks Trading Halt
Australia's Chimeric Therapeutics rises on positive data for its cell therapy clinical trial